Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Melinta Therapeutics, Inc Snapshot 5 Melinta Therapeutics, Inc Overview 5 Key Information 5 Key Facts 5 Melinta Therapeutics, Inc - Research and Development Overview 6 Key Therapeutic Areas 6 Melinta Therapeutics, Inc - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Melinta Therapeutics, Inc - Pipeline Products Glance 11 Melinta Therapeutics, Inc - Late Stage Pipeline Products 11 Phase III Products/Combination Treatment Modalities 11 Melinta Therapeutics, Inc - Clinical Stage Pipeline Products 12 Phase II Products/Combination Treatment Modalities 12 Melinta Therapeutics, Inc - Early Stage Pipeline Products 13 Preclinical Products/Combination Treatment Modalities 13 Discovery Products/Combination Treatment Modalities 14 Melinta Therapeutics, Inc - Drug Profiles 15 delafloxacin 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 radezolid 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 RX-02 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 RX-04 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 RX-05 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 RXP-792 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 RXP-873 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 RXP-763 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 RXP-766 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 RXP-770 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 RXP-793 32 Product Description 32 Mechanism of Action 32 R&D Progress 32 RXP-808 33 Product Description 33 Mechanism of Action 33 R&D Progress 33 Melinta Therapeutics, Inc - Pipeline Analysis 34 Melinta Therapeutics, Inc - Pipeline Products by Target 34 Melinta Therapeutics, Inc - Pipeline Products by Route of Administration 35 Melinta Therapeutics, Inc - Pipeline Products by Molecule Type 36 Melinta Therapeutics, Inc - Pipeline Products by Mechanism of Action 37 Melinta Therapeutics, Inc - Recent Pipeline Updates 38 Melinta Therapeutics, Inc - Dormant Projects 46 Melinta Therapeutics, Inc - Company Statement 47 Melinta Therapeutics, Inc - Locations And Subsidiaries 48 Head Office 48 Other Locations & Subsidiaries 48 Appendix 49 Methodology 49 Coverage 49 Secondary Research 49 Primary Research 49 Expert Panel Validation 49 Contact Us 49 Disclaimer 50

List of Tables Melinta Therapeutics, Inc, Key Information 5 Melinta Therapeutics, Inc, Key Facts 5 Melinta Therapeutics, Inc - Pipeline by Indication, 2016 7 Melinta Therapeutics, Inc - Pipeline by Stage of Development, 2016 9 Melinta Therapeutics, Inc - Monotherapy Products in Pipeline, 2016 10 Melinta Therapeutics, Inc - Phase III, 2016 11 Melinta Therapeutics, Inc - Phase II, 2016 12 Melinta Therapeutics, Inc - Preclinical, 2016 13 Melinta Therapeutics, Inc - Discovery, 2016 14 Melinta Therapeutics, Inc - Pipeline by Target, 2016 34 Melinta Therapeutics, Inc - Pipeline by Route of Administration, 2016 35 Melinta Therapeutics, Inc - Pipeline by Molecule Type, 2016 36 Melinta Therapeutics, Inc - Pipeline Products by Mechanism of Action, 2016 37 Melinta Therapeutics, Inc - Recent Pipeline Updates, 2016 38 Melinta Therapeutics, Inc - Dormant Developmental Projects,2016 46 Melinta Therapeutics, Inc, Other Locations 48 List of Figures Melinta Therapeutics, Inc - Pipeline by Top 10 Indication, 2016 7 Melinta Therapeutics, Inc - Pipeline by Stage of Development, 2016 9 Melinta Therapeutics, Inc - Monotherapy Products in Pipeline, 2016 10 Melinta Therapeutics, Inc - Pipeline by Target, 2016 34 Melinta Therapeutics, Inc - Pipeline by Route of Administration, 2016 35 Melinta Therapeutics, Inc - Pipeline by Molecule Type, 2016 36 Melinta Therapeutics, Inc - Pipeline Products by Mechanism of Action, 2016 37